Global Blood Therapeutics (GBT) CAPEX/Revenue US GAAP (year values)

2017 2018 2019 2020 2021   LTM ? CAGR 5 years ?
CAPEX/Revenue, % 164.1% 7.07% 1.66%   0.83%  
Changes by years, y/y, % -157pp -5pp     -89.9%

Global Blood Therapeutics. CAPEX/Revenue, %

Created with Highcharts 6.0.6164.1164.17.17.11.71.70.80.8201920202021LTM0255075100125150175smart-lab.ru

Global Blood Therapeutics. CAPEX/Revenue, changes, pp

Created with Highcharts 6.0.6-157.1-157.1-5.4-5.4-0.8-0.820202021LTM-175-150-125-100-75-50-250smart-lab.ru

Global Blood Therapeutics (GBT) CAPEX/Revenue US GAAP (quarter values)

2021Q2 2021Q3 2021Q4 2022Q1 2022Q2   LTM ?
CAPEX/Revenue, % 1.66% 0.50% 1.88% 0.46% 0.54%   0.83%
Changes by years, y/y, % -3pp 0pp -9pp -2pp -1pp    
Changes by quarters, q/q, % -1pp -1pp +1pp -1pp +0pp    

Global Blood Therapeutics. CAPEX/Revenue, %

Created with Highcharts 6.0.6107.3107.317.917.94.44.40.70.711.111.12.92.91.71.70.50.51.91.90.50.50.50.52019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q20255075100125smart-lab.ru

Global Blood Therapeutics. CAPEX/Revenue, changes, pp

Created with Highcharts 6.0.6-96.3-96.3-15.0-15.0-2.8-2.8-0.2-0.2-9.2-9.2-2.4-2.4-1.1-1.12020Q42021Q12021Q22021Q32021Q42022Q12022Q2-120-100-80-60-40-200smart-lab.ru

Global Blood Therapeutics. CAPEX/Revenue, changes, pp

Created with Highcharts 6.0.6-89.4-89.4-13.5-13.5-3.7-3.710.310.3-8.2-8.2-1.2-1.2-1.2-1.21.41.4-1.4-1.40.10.12020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q2-100-80-60-40-20020smart-lab.ru